Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
29,063
Price
$44.58
Total Value
$1.30M
Shares Held After
3,530,702
% of Holdings
0.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
12,528
Price
$45.27
Total Value
$567.14K
Shares Held After
12,546
% of Holdings
50.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Hodgson Ian — Chief Operating Officer
Shares
2,415
Price
$8.09
Total Value
$19.54K
Shares Held After
51,927
% of Holdings
4.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Smethurst Dominic — Chief Medical Officer
Shares
3,285
Price
$8.09
Total Value
$26.57K
Shares Held After
95,887
% of Holdings
3.3%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Schafer Joshua — CCO
Shares
10,500
Price
$9.19
Total Value
$96.50K
Shares Held After
62,278
% of Holdings
14.4%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Sangiovanni Timothy J. — SVP, Finance & Corp Controller
Shares
3,000
Price
$9.18
Total Value
$27.55K
Shares Held After
29,590
% of Holdings
9.2%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
6,195
Price
$42.84
Total Value
$265.41K
Shares Held After
23,972
% of Holdings
20.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
108,759
Price
$42.84
Total Value
$4.66M
Shares Held After
183,656
% of Holdings
37.2%
Karyopharm Therapeutics Inc. (KPTI)
Macomber Lori — EVP, CFO & Treasurer
Shares
1,626
Price
$6.30
Total Value
$10.24K
Shares Held After
85,105
% of Holdings
1.9%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
795
Price
$155.77
Total Value
$123.84K
Shares Held After
84,112
% of Holdings
0.9%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
640
Price
$156.27
Total Value
$100.01K
Shares Held After
56,397
% of Holdings
1.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,009
Price
$156.34
Total Value
$470.43K
Shares Held After
303,882
% of Holdings
1.0%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
748
Price
$156.34
Total Value
$116.94K
Shares Held After
79,758
% of Holdings
0.9%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
791
Price
$156.17
Total Value
$123.53K
Shares Held After
106,810
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
7,175
Price
$32.12
Total Value
$230.46K
Shares Held After
108,205
% of Holdings
6.2%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
12,446
Price
$32.87
Total Value
$409.10K
Shares Held After
109,087
% of Holdings
10.2%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
4,333
Price
$32.12
Total Value
$139.18K
Shares Held After
49,080
% of Holdings
8.1%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — CHIEF COMMERCIAL OFFICER
Shares
7,310
Price
$32.12
Total Value
$234.80K
Shares Held After
131,823
% of Holdings
5.3%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
7,242
Price
$32.12
Total Value
$232.61K
Shares Held After
112,971
% of Holdings
6.0%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
33,635
Price
$32.70
Total Value
$1.10M
Shares Held After
432,886
% of Holdings
7.2%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
66,452
Price
$32.06
Total Value
$2.13M
Shares Held After
466,521
% of Holdings
12.5%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
6,956
Price
$32.12
Total Value
$223.43K
Shares Held After
107,485
% of Holdings
6.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,177
Price
$21.94
Total Value
$47.76K
Shares Held After
641,682
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,178
Price
$21.94
Total Value
$47.79K
Shares Held After
641,685
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$474.23
Total Value
$23.71K
Shares Held After
270
% of Holdings
15.6%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
18,891
Price
$2.20
Total Value
$41.56K
Shares Held After
788,853
% of Holdings
2.3%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
18,442
Price
$2.20
Total Value
$40.57K
Shares Held After
1,100,008
% of Holdings
1.6%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
7,039
Price
$18.02
Total Value
$126.84K
Shares Held After
358,234
% of Holdings
1.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
14,043
Price
$32.87
Total Value
$461.59K
Shares Held After
657,540
% of Holdings
2.1%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
957
Price
$31.82
Total Value
$30.45K
Shares Held After
671,583
% of Holdings
0.1%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
2,540
Price
$2.55
Total Value
$6.48K
Shares Held After
187,286
% of Holdings
1.3%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
5,455
Price
$9.14
Total Value
$49.86K
Shares Held After
383,837
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
4,714
Price
$25.63
Total Value
$120.82K
Shares Held After
110,003
% of Holdings
4.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
19,379
Price
$25.24
Total Value
$489.13K
Shares Held After
114,717
% of Holdings
14.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
8,562
Price
$24.97
Total Value
$213.79K
Shares Held After
134,096
% of Holdings
6.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
7,983
Price
$25.50
Total Value
$203.55K
Shares Held After
142,658
% of Holdings
5.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
1,890
Price
$44.57
Total Value
$84.24K
Shares Held After
3,559,765
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
34,668
Price
$18.60
Total Value
$644.82K
Shares Held After
1,187,644
% of Holdings
2.8%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
100
Price
$66.89
Total Value
$6.69K
Shares Held After
183,371
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,108
Price
$66.15
Total Value
$73.29K
Shares Held After
183,471
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
792
Price
$65.21
Total Value
$51.65K
Shares Held After
184,579
% of Holdings
0.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
1,320
Price
$25.50
Total Value
$33.66K
Shares Held After
63,607
% of Holdings
2.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Edwards Larry Todd — Reporting Person's title: EVP Chief Commercial Officer
Shares
2,052
Price
$25.50
Total Value
$52.32K
Shares Held After
148,865
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$25.05
Total Value
$250.48K
Shares Held After
59,744
% of Holdings
14.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
19,833
Price
$25.50
Total Value
$505.71K
Shares Held After
721,306
% of Holdings
2.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
3,675
Price
$25.50
Total Value
$93.71K
Shares Held After
90,445
% of Holdings
3.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
124,998
Price
$18.44
Total Value
$2.30M
Shares Held After
2,459,245
% of Holdings
4.8%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
1,890
Price
$44.57
Total Value
$84.24K
Shares Held After
3,559,765
% of Holdings
0.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
830
Price
$45.00
Total Value
$37.35K
Shares Held After
12,546
% of Holdings
6.2%
Allogene Therapeutics, Inc. (ALLO)
Parker Geoffrey M. — CHIEF FINANCIAL OFFICER
Shares
24,001
Price
$1.76
Total Value
$42.24K
Shares Held After
1,252,795
% of Holdings
1.9%
Showing 801–850 of 936 transactions (page 17 of 19)